In Conversation With 2020 Top Doctor Ronald Torrance, II, D.O. On Innovation In Sports Medicine

BrandStory

For the January 2021 edition of SRQ Magazine, we interviewed 2020 Top Doctors on current topics. Below is an excerpt from this published in the In Conversation marketing feature in which Dr. Ronald Torrance, II of Regenexx Tampa Bay shares his insights on innovations in sports medicine.  

What are a few of the most exciting treatments in your field?

The innovations that we're really pioneering are looking at percutaneous ways to repair partial tears of the rotator cuff, and partial tears of the ACL where you don't have to go through arthroscopic surgery. We have two randomized control trials on each, showing that we can percutaneously help regenerate these injuries. So you don't have to necessarily have to go to surgery to get these areas to heal. Our CEO has a mission for Regenexx that our innovations reduce the number of elective orthopedic surgeries by 70% by 2030. I feel with the new modalities coming for the people, it's a certainly attainable mission.

An excerpt from the In Conversation with Top Doctors published in the January 2021 edition of SRQ Magazine. Click here to see the full article. 

Read More From In Conversation Here

« View The Monday Jan 18, 2021 SRQ Daily Edition
« Back To SRQ Daily Archive

Read More

Affording Art School: Making the Impossible Possible

Affording Art School: Making the Impossible Possible

Dr. Larry Thompson | Nov 23, 2024

Can Trump Set Off a Chain of Local Dominoes?

Can Trump Set Off a Chain of Local Dominoes?

Jacob Ogles | Nov 23, 2024

  Westcoast Black Theatre Troupe Launches Seven-Year, $10M Solid Gold Campaign

Westcoast Black Theatre Troupe Launches Seven-Year, $10M Solid Gold Campaign

Nov 22, 2024

Gary LaParl's Unveiled Strength: Portraits of Intimacy and Vulnerability Explores Themes of Male Relationships and Vulnerability

Gary LaParl's Unveiled Strength: Portraits of Intimacy and Vulnerability Explores Themes of Male Relationships and Vulnerability

Nov 22, 2024